$VKTX
Viking Therapeutics, Inc
XNAS•Health Care•Pharmaceutical Preparations
$28.99
▼-1.25%-$0.366
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateViking Therapeutics, Inc
XNAS•Health Care•Pharmaceutical Preparations
Why is VKTX down today? It is at $28.99 (-1.25%), and our scanner flagged it 143 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment VKTX spikes, and full due diligence on VKTX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $VKTX 143 times in the last 30 days. Create a free account to track $VKTX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on VKTX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for VKTX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Kelly-Gemmell Dorothy Elizabeth Director | Acquired (grant/award) | +6K | n/a | 6K | n/a | Aug 1, 26 |
Mancini Marianna Officer | Sold (automatic/other) | -18K 0.02% of company | sold 4.1% | 423K | $610K at $33.47 | Jul 29, 26 |
Zante Greg Officer | Sold (automatic/other) | -21K 0.02% of company | sold 9.1% | 212K | $710K at $33.47 | Jul 29, 26 |
Lian Brian Officer | Sold (automatic/other) | -149K 0.1% of company | sold 5.5% | 2.57M | $4.9M at $33.32 | Jul 29, 26 |
Mancini Marianna Officer | Acquired (grant/award) | +32K 0.03% of company | added 7.7% | 441K | n/a | Jul 28, 26 |
Zante Greg Officer | Acquired (grant/award) | +32K 0.03% of company | added 16% | 233K | n/a | Jul 28, 26 |
Lian Brian Officer | Acquired (grant/award) | +222K 0.2% of company | added 8.9% | 2.72M | n/a | Jul 28, 26 |
Aubuchon Neil William Officer | Bought (open market) | +4K | n/a | 4K | $150K at $33.50 | Mar 10, 26 |
Lian Brian Officer | Sold (automatic/other) | -233K 0.2% of company | sold 8.5% | 2.50M | $7.5M at $32.29 | Jan 5, 26 |
Mancini Marianna Officer | Sold (automatic/other) | -58K 0.05% of company | sold 12% | 409K | $1.9M at $32.29 | Jan 5, 26 |
Zante Greg Officer | Sold (automatic/other) | -58K 0.05% of company | sold 23% | 190K | $1.9M at $32.09 | Jan 5, 26 |
Rouan Sarah Kathryn Director | Acquired (grant/award) | +3K | added 100% | 4K | n/a | Jan 2, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on VKTX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for VKTX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
VKTX last traded at $28.99, down 1.25% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Viking Therapeutics, Inc (VKTX) is next expected to report earnings on Wednesday, October 28, 2026, about 38 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The VKTX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged VKTX 143 times in the last 30 days.
VKTX (Viking Therapeutics, Inc) trades on XNAS, with a market cap of about $3.38B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge VKTX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$VKTX discussion
Sign in to ask a question or join the discussion.